Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    supriya kashyap kashyap
    supriya kashyap kashyap
      • Home
      • supriya kashyap...

      Articles By : supriya kashyap kashyap

      Natcos partner Alvogen gets nod for influenza drug in US

      Natco's partner Alvogen gets nod for influenza drug in US

      supriya kashyap kashyap6 Nov 2017 10:30 AM IST
      New Delhi: Natco Pharma said its marketing partner Alvogen has received final approval to market oseltamivir phosphate powder used for the treatment...
      USFDA moves to more efficient global pharmaceutical manufacturing inspections

      USFDA moves to more efficient global pharmaceutical manufacturing inspections

      supriya kashyap kashyap6 Nov 2017 9:50 AM IST
      The U.S. Food and Drug Administration has determined the agency will recognize eight European drug regulatory authorities as capable of conducting...
      Sanofi refines expectations on drop in sales at diabetes arm

      Sanofi refines expectations on drop in sales at diabetes arm

      supriya kashyap kashyap6 Nov 2017 9:45 AM IST
      Paris: Sanofi confirmed its 2017 outlook after it posted slightly lower-than-expected third-quarter results, and gave a more precise range on...
      Pfizer expects broad interest for consumer health business

      Pfizer expects broad interest for consumer health business

      supriya kashyap kashyap6 Nov 2017 9:30 AM IST
      New York: Pfizer Inc, the largest U.S. drugmaker, expects no shortage of suitors for its consumer health business and said it would decide whether to...
      US states allege broad generic drug price-fixing collusion

      US states allege broad generic drug price-fixing collusion

      supriya kashyap kashyap5 Nov 2017 1:06 PM IST
      Washington: A large group of US states accused key players in the generic drug industry of a broad price-fixing conspiracy, moving to widen an earlier...
      AstraZeneca asthma drug tralokinumab disappoints again

      AstraZeneca asthma drug tralokinumab disappoints again

      supriya kashyap kashyap5 Nov 2017 9:50 AM IST
      London: An experimental biotech drug for severe asthma from AstraZeneca has failed in further clinical tests, following an earlier setback in May and...
      GSK gets boost for early cancer hopes with breakthrough status

      GSK gets boost for early cancer hopes with breakthrough status

      supriya kashyap kashyap5 Nov 2017 9:15 AM IST
      London: GlaxoSmithKline received a boost for its oncology research on Thursday when an experimental drug for blood cancer received a "breakthrough"...
      Torrent Pharma to buy Unichem Labs India business for $558 million

      Torrent Pharma to buy Unichem Labs India business for $558 million

      supriya kashyap kashyap4 Nov 2017 3:24 PM IST
      Torrent Pharmaceuticals said it would buy more than 120 brands from Unichem Laboratories in India and Nepal, and its manufacturing plant at Sikkim.The...
      Natco Pharma Q2 net up 27 pc at Rs 84 crores

      Natco Pharma Q2 net up 27 pc at Rs 84 crores

      supriya kashyap kashyap4 Nov 2017 2:30 PM IST
      New Delhi: Natco Pharma today reported a 27.49 percent rise in consolidated net profit to Rs 84.4 crore for the second quarter ended September 30,...
      AstraZeneca licenses genetic disease drug to Mereo BioPharma

      AstraZeneca licenses genetic disease drug to Mereo BioPharma

      supriya kashyap kashyap4 Nov 2017 10:06 AM IST
      London: Mereo BioPharma has agreed a licensing deal and acquisition option for a rare disease drug from AstraZeneca as the big drugmaker continues to...
      Teva shares topple on profit warning, uncertain future

      Teva shares topple on profit warning, uncertain future

      supriya kashyap kashyap4 Nov 2017 9:47 AM IST
      JERUSALEM: Teva Pharmaceutical Industries (TEVA.TA), the world’s biggest generic medicine maker, came under investor and market pressure after saying...
      GSK and Gilead go head to head as HIV drugs enter new phase

      GSK and Gilead go head to head as HIV drugs enter new phase

      supriya kashyap kashyap4 Nov 2017 9:47 AM IST
      London: Gilead Sciences (GILD.O) and GlaxoSmithKline (GSK.L) are heading for an HIV showdown, pushing rival treatment visions and competing products...
      Next

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok